Universal Health Services, Inc. (UHS)
Universal Health Services, Inc. (UHS) is a healthcare company (medical care facilities) based in the United States. The share price is $194.50, down 1.67% on the day, which values the company at $11.21B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.
Key facts
- Share price
- $194.50−1.67% today
- Market value
- $11.21B
- P/E ratio
- 8.1×last 12 months
- Forward P/E
- 8.5×
- Dividend yield
- 0.40%
- Funk Score
- 63/100
- Against its own history
- Below its usual priceusual price $233.85
- 200-week average
- $174.8411% above
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Universal Health Services, Inc. in more detail
UHS trades at 8.1× its last twelve months' earnings, 8.5× next year's expected earnings, 0.6× sales. Measured against its own history, the price is 17% below what its usual multiples would imply ($233.85) — below its usual price. It sits 11% above its 200-week average of $174.84.
Over the last five fiscal years Universal Health Services, Inc. has compounded revenue 8.5% a year, earnings per share 16.0% a year, free cash flow -12.7% a year. Its Funk Score is 63 out of 100 (financial strength 6.2, profitability 5.2, growth 5.6, value 8.4, each out of 10).
In its favour: Altman Z in the safe zone; Strong Piotroski score.
5 of the superinvestors tracked here hold UHS, including Richard Pzena (1.3% of the portfolio), Matthew McLennan (1.3% of the portfolio), Louis Bacon (0.7% of the portfolio).
Superinvestors holding UHS
5 of the investors tracked here report a position in their latest 13F filing.
- Richard Pzena Pzena Investment Management1.33% of portfolio · $454.3M · added · Q3 2026
- Matthew McLennan First Eagle Investment Management1.25% of portfolio · $795.7M · added · Q3 2026
- Louis Bacon Moore Capital Management0.66% of portfolio · $23.3M · trimmed · Q3 2026
- Josef Lakonishok LSV Asset Management0.30% of portfolio · $162.4M · trimmed · Q3 2026
- Ray Dalio (founder) Bridgewater Associates0.14% of portfolio · $33.9M · added · Q2 2026
Health Care companies of similar size
- Dr. Reddy's LaboratoriesRDY
- Align TechnologyALGN
- Cooper CompaniesCOO
- Fresenius Medical CareFMS
- Kymera TherapeuticsKYMR
- DaVitaDVA
- Halozyme TherapeuticsHALO
- RepligenRGEN
- Bio-TechneTECH
- BioMarin PharmaceuticalBMRN
- AvantorAVTR
- Ensign GroupENSG
Side by side:UHS vs HALO (Universal Health Services, Inc. vs Halozyme Therapeutics)UHS vs RGEN (Universal Health Services, Inc. vs Repligen)UHS vs DVA (Universal Health Services, Inc. vs DaVita)UHS vs TECH (Universal Health Services, Inc. vs Bio-Techne)UHS vs KYMR (Universal Health Services, Inc. vs Kymera Therapeutics)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Universal Health Services, Inc. (UHS): questions and answers
What is UHS's P/E ratio?
Universal Health Services, Inc. trades at 8.1× its last twelve months' earnings and 8.5× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 9.4× to 20.5×, with a median of 14.3×.
What is UHS's PEG ratio?
Universal Health Services, Inc.'s PEG ratio is 1.47 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Universal Health Services, Inc.'s market cap?
Universal Health Services, Inc. is valued at $11.21B at a share price of $194.50.
Is UHS overvalued or undervalued?
Against its own history, UHS is below its usual price: the price is 17% below the $233.85 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is UHS above its 200-week moving average?
Yes. UHS is 11.2% above its 200-week average of $174.84. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Universal Health Services, Inc. growing?
Over the last five fiscal years Universal Health Services, Inc.'s revenue grew 8.5% a year and its earnings per share 16.0% a year; over ten years revenue grew 6.7% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Universal Health Services, Inc. (UHS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/UHS
Underlying data: Yahoo Finance; company filings with the SEC.